Literature DB >> 28191511

China may hold answers to addressing cardiovascular disease epidemic.

Richard A Chazal1.   

Abstract

Entities:  

Year:  2016        PMID： 28191511      PMCID： PMC5290908          DOI： 10.1515/jtim-2016-0003

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN： 2224-4018


× No keyword cloud information.
  8 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

2.  Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results.

Authors:  Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2014-08-05       Impact factor: 24.094

3.  Status of cardiovascular health in Chinese adults.

Authors:  Yufang Bi; Yong Jiang; Jiang He; Yu Xu; Limin Wang; Min Xu; Mei Zhang; Yichong Li; Tiange Wang; Meng Dai; Jieli Lu; Mian Li; Chung-Shiuan Chen; Shenghan Lai; Weiqing Wang; Linhong Wang; Guang Ning
Journal:  J Am Coll Cardiol       Date:  2015-03-17       Impact factor: 24.094

4.  A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.

Authors:  Kaveh Hajifathalian; Peter Ueda; Yuan Lu; Mark Woodward; Alireza Ahmadvand; Carlos A Aguilar-Salinas; Fereidoun Azizi; Renata Cifkova; Mariachiara Di Cesare; Louise Eriksen; Farshad Farzadfar; Nayu Ikeda; Davood Khalili; Young-Ho Khang; Vera Lanska; Luz León-Muñoz; Dianna Magliano; Kelias P Msyamboza; Kyungwon Oh; Fernando Rodríguez-Artalejo; Rosalba Rojas-Martinez; Jonathan E Shaw; Gretchen A Stevens; Janne Tolstrup; Bin Zhou; Joshua A Salomon; Majid Ezzati; Goodarz Danaei
Journal:  Lancet Diabetes Endocrinol       Date:  2015-03-26       Impact factor: 32.069

5.  Changing characteristics of the type 2 diabetes epidemic of China and other Asian countries.

Authors:  Wenying Yang
Journal:  J Diabetes Investig       Date:  2013-05-06       Impact factor: 4.232

6.  Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control.

Authors:  Yuanxiu Huang; Lin Gao; Xiaoping Xie; Seng Chuen Tan
Journal:  Popul Health Metr       Date:  2014-10-28

7.  HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.

Authors: 
Journal:  Eur Heart J       Date:  2013-02-26       Impact factor: 29.983

8.  Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.

Authors:  Huan He; Ya-qin Yu; Yong Li; Chang-gui Kou; Bo Li; Yu-chun Tao; Qing Zhen; Chang Wang; Joseph Sam Kanu; Xu-feng Huang; Mei Han; Ya-wen Liu
Journal:  Lipids Health Dis       Date:  2014-08-03       Impact factor: 3.876
  8 in total
  1 in total

Review 1.  Circular RNAs in thoracic diseases.

Authors:  Fan Yang; Ping Zhu; Jintao Guo; Xiang Liu; Sheng Wang; Guoxin Wang; Wen Liu; Shupeng Wang; Nan Ge
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.